Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Get the Prostate.net RSS feed

Category Archives: Prostate Cancer

  • Related Categories
    • No categories

Does Hormone Therapy Increase Risk of Heart Attack?

by Editor on December 8 Leave the first comment

Men with prostate cancer who are considering hormone therapy or who are already on hormone therapy may be encouraged by the results of a new study appearing in the Journal of the American Medical Association. The meta-analysis found that hormone therapy did not increase the risk of cardiovascular deaths, plus it showed a lower risk… Continue Reading »


More about:

Hormone Therapy and Blood Clot Risk for Prostate Cancer Patients

by Deborah Mitchell on December 2 Leave the first comment

For men with prostate cancer who are being treated with hormone therapy, news of a potentially dangerous side effect of hormone therapy associated with their prostate cancer treatment suggests it’s time to talk to their doctor. A large study conducted by researchers at Memorial-Sloan Kettering Cancer Center found that older men with prostate cancer who… Continue Reading »


More about:

Red Meat Increases Prostate Cancer Risk

by Editor on November 25 Leave the first comment

Recent studies show the increased association between red meat and prostate cancer including an increased risk of prostate cancer when meat was grilled at high temperatures. In addition, men who ate the most ground beef were 2.3 times more likely than men who ate none to have aggressive prostate cancer. Read more


More about:

Radionuclide Therapy for Prostate Cancer Treatment

by Editor on November 8 Leave the first comment

For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November issue of The Journal of Nuclear Medicine. Read more


More about:

MDV 3100 (Medivation and Astellas) For Prostate Cancer Treatment

by Editor on November 8 Leave the first comment

Fast on the heels of five new prostate cancer drugs approved for patients with advanced disease in the past 18 months, a promising new drug, MDV3100 (Medivation and Astellas), should soon be approved by the FDA for patients who have failed hormone therapy and chemotherapy with docetaxel. “The clinical advancement of MDV3100 is one of… Continue Reading »


More about:

Amino Acid (Leucine) in Meat and Dairy May Cause Prostate Cancer

by Editor on November 5 Leave the first comment

Researchers at The Centenary Institute in Sydney, Australia have discovered a potential future treatment for prostate cancer — through starving the tumour cells of an essential nutrient they need to grow rapidly. Each year about 3,300 Australian men die of prostate cancer. It’s Australia’s second worst cancer killer for men, matching the impact of breast… Continue Reading »


More about:

Don’t Believe The Hype About Vitamin E and Prostate Cancer

by James Craig on October 21 Leave the first comment

Does taking vitamin E increase your risk of prostate cancer? If you have seen the new study published in the Journal of the American Medical Association (JAMA)about the extended findings of the SELECT trial which stated that vitamin E can increase the risk of prostate cancer, don’t panic. There are some important things you should know about the… Continue Reading »


More about:

Are Older Men Undertreated for Prostate Cancer?

by Deborah Mitchell on September 27 Leave the first comment

To treat or not to treat prostate cancer? That is frequently the question when it comes to older men and treatment for prostate cancer. Is it feasible to subject men who are, say, 75 years and older to prostate cancer treatments that may cause them significant side effects given they may not live much longer?… Continue Reading »


More about: ,

New Prostate Cancer Drug Alpharadin Improves Survival

by Deborah Mitchell on September 24 Leave the first comment

It’s not often that the monitoring committee during a Phase III trial ends the study early because the drug has performed so well, but that’s what happened with the new prostate cancer drug, Alpharadin. The investigators report that men with metastatic, hormone-resistant prostate cancer lived a median of three months longer when taking Alpharadin.


More about: , ,

Can Vegetables Reduce Risk Of Aggressive Prostate Cancer?

by Deborah Mitchell on September 5 Leave the first comment

Pile up the spinach and other leafy greens, and while you’re at it, add some carrots and tomatoes, too. A new study from the University of California at San Francisco (UCSF) reports that men whose diets are high in leafy green vegetables and vegetables high in carotenoids have a reduced risk of aggressive prostate cancer.


More about:

  • ADVERTISEMENT



  • ADVERTISEMENT